List of Prostate Cancer Therapies Received by Patients in This Study in Follow-up Period After 18F-DCFBC PET Imaging
| Patient no. | Therapy after 18F-DCFBC PET | Time to imaging follow-up | Follow-up imaging modalities available |
| 1 | Started sipuleucel-T | 6 mo | Na18F PET/CT |
| 2 | Started androgen deprivation | 4 mo | BS |
| 3 | Continued androgen deprivation | NA | NA |
| 4 | Started androgen deprivation | 2 mo | CECT, BS |
| 5 | Started androgen deprivation | 6 mo | CECT, BS |
| 6 | Started cabazitaxel | 4 mo | CECT, BS |
| 7 | Entered hospice | NA | NA |
| 8 | Continued androgen deprivation | NA | NA |
| 9 | External-beam radiation to the pelvis, continued androgen deprivation | 4 mo | CECT, BS |
| 10 | Started androgen deprivation | NA | NA |
| 11 | Started androgen deprivation | 6 mo | CECT, BS |
| 12 | Continued 223Ra | 3 mo | CECT, BS |
| 13 | Started androgen deprivation | 1 y | PSMA PET/CT |
| 14 | External-beam radiation to pelvic lymph node, started nelfinavir | 3 mo | CECT |
| 15 | Continued androgen deprivation, started veliparib | 3 mo | CECT, BS |
| 16 | No follow-up information available | NA | NA |
| 17 | Started androgen deprivation | 1 mo | CECT |
Time to follow-up and available modalities at follow-up are also noted. Patient 13 underwent follow-up PET/CT imaging with PSMA-targeted radiotracer (18F-DCFPyL) different from radiotracer primarily described here.
NA = not available.